Cytochrome P450 3A4-Mediated Interaction of Diclofenac and Quinidine
Authors:
- Wei TangWTWei Tang
- Ralph A. StearnsRSRalph A. Stearns
- Magang ShouMSMagang Shou
- Randall R. MillerRMRandall R. Miller
- Yong ZhangYZYong Zhang
- Jiunn H. LinJLJiunn H. Lin
- Thomas A. BaillieTBThomas A. Baillie
- 1 September 2000
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 28 (9) , 1043-1050
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cooperativity in Oxidations Catalyzed by Cytochrome P450 3A4Biochemistry, 1997
- Role of Cytochrome P450 Enzymes in Drug-Drug Interactions1997
- Toxicity of Allyl Alcohol in Primary Cultures of Freshly Isolated and Cryopreserved Hepatocytes Maintained on Hydrated Collagen GelsToxicology and Applied Pharmacology, 1997
- Interindividual variability in catalytic activity and immunoreactivity of three major human liver cytochrome P450 isozymesEuropean Journal of Clinical Pharmacology, 1996
- Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactionsHepatology, 1995
- Human liver carbamazepine metabolismBiochemical Pharmacology, 1994
- Activation of CYP3A4: Evidence for the Simultaneous Binding of Two Substrates in a Cytochrome P450 Active SiteBiochemistry, 1994
- Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liverLife Sciences, 1993
- Isolation, characterisation and synthesis of a new quinidine metaboliteEuropean Journal of Drug Metabolism and Pharmacokinetics, 1982
- The extinction coefficient of cytochrome cBiochimica et Biophysica Acta, 1962